Childhood cancers trials in Poland

In Poland 49 Also abroad 2459

49 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Study to evaluate the safety and efficacy of asciminib in pediatric participants with chronic myeloid leukemia.
Where
Gdansk, Wroclaw
Age
Up to 17 years
People
16 worldwide
Run by
Novartis Pharma AG
See details and how to join2025-522138-29-00 · EU 2025-522138-29-00
Phase 2Taking people
Revumenib Treatment in Combination with FLA Chemotherapy in Paediatric Refractory/Relapsed KMT2A-r, NUP98-r or NPM1-mut Acute Myeloid Leukemia (AML)
Where
Cracow, Gdansk, Poznan, Wroclaw
Age
Up to 64 years
People
31 worldwide
Run by
Pediatric Research International GmbH
See details and how to join2025-521390-14-00 · EU 2025-521390-14-00
Phase 3Taking people
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
Where
Cracow, Gdansk, Warsaw
Age
12 years and over
People
400 worldwide
Run by
Replimune, Inc.
See details and how to joinNCT06264180 · EU 2023-508612-29-00
Phase 1/2Taking people
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Where
Warsaw
Age
12 years and over
People
361 worldwide
Run by
ModernaTX, Inc.
See details and how to joinNCT05533697 · EU 2023-504506-11-00
Phase 3Taking people
Fight Osteosarcoma Through European Research evolving study platform from diagnosis to relapse (FOSTER evolving study platform)
Where
Warsaw
People
508 worldwide
Run by
Institut Gustave Roussy
See details and how to join2023-505575-69-01 · EU 2023-505575-69-01
No phaseTaking people
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
Where
Gdansk, Gliwice, Poznan, Warsaw
Age
12 years and over
People
4,975 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT02834884
Phase 2Taking people
Clinical trial (study) comparing the efficacy and safety of mifamurtide versus standard treatment containing sorafenib in pediatric and young adult patients with high-risk osteosarcoma
Where
Warsaw
Age
Up to 64 years
People
40
Run by
Instytut Matki I Dziecka
See details and how to join2026-525223-24-00 · EU 2026-525223-24-00
Phase 1/2Taking people
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Where
Gdansk, Warsaw
Age
12 years and over
People
500 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00
Phase 3Taking people
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Where
Bialystok, Bydgoszcz, Cracow, Gdansk, Katowice, Kielce, Lodz, Lublin, Olsztyn, Poznan, Rzeszów, Szczecin, Warsaw, Wroclaw, Zabrze
Age
Up to 18 years
People
683 worldwide
Run by
University Hospital Muenster
See details and how to joinNCT04043494 · EU 2023-508101-24-00
Phase 2/3Taking people
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Where
Warsaw
Age
18 years and over
People
280 worldwide
Run by
Replimune, Inc.
See details and how to joinNCT06581406 · EU 2023-508784-68-00
Phase 2Taking people
International Study for Treatment of High Risk Childhood Relapsed ALL 2010
Where
Lodz, Lublin, Wroclaw
Age
Up to 17 years
People
250 worldwide
Run by
Charite University, Berlin, Germany
See details and how to joinNCT03590171 · EU 2024-513070-21-00
Phase 1/2Taking people
Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors
Where
Cracow
Age
1 year to 25 years
People
65 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT04925609 · EU 2024-513412-10-00
Phase 3Taking people
Endoscopic Therapy Or Surgery for Early Colon Cancer
Where
Gdansk
People
434
Run by
Norwegian Department of Health and Social Affairs
See details and how to joinNCT06940947
No phaseTaking people
Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.
Where
Gdynia
People
248
Run by
PCK Marine Hospital in Gdynia
See details and how to joinNCT06574087
Phase 1Taking people
Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma
Where
Cracow
Age
18 months to 18 years
People
38 worldwide
Run by
Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT06485947 · EU 2023-509673-22-00
Phase 3Taking people
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Where
Gdansk, Kraków, Warsaw, Wrocław
Age
Up to 21 years
People
800 worldwide
Run by
Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT04221035 · EU 2024-514917-36-00
No phaseTaking people
International Rare Histiocytic Disorders Registry (IRHDR)
Where
Warsaw
People
400 worldwide
Run by
The Hospital for Sick Children
See details and how to joinNCT02285582
Phase 3Taking people
A clinical trial in children and adolescents with primary malignant liver cancer - Hepatoblastoma and Hepatocarcinoma
Where
Białystok, Bydgoszcz, Gdansk, Katowice, Krakow, Łódź, Lublin, Poznań, Rzeszów, Szczecin, Warsaw, Wrocław, Zabrze
Age
Up to 64 years
People
60
Run by
Medical University Of Gdansk
See details and how to join2024-514635-26-00 · EU 2024-514635-26-00
Phase 2Taking people
Phase 2a non-commercial and non-randomized intervention study evaluating the efficacy of crizotinib in the treatment of children with severe type 2 neurofibromatosis, in particular those excluded from surgery and / or radiotherapy
Where
Warsaw
Age
Up to 17 years
People
1
Run by
Medical University Of Warsaw
See details and how to join2024-516607-16-00 · EU 2024-516607-16-00
Phase 2Taking people
Study of the effectiveness of drugs selected depending on the molecular profile of diffuse intrinsic pontine glioma (DIPG).
Where
Katowice, Warsaw
Age
Up to 64 years
People
100
Run by
Instytut Pomnik Centrum Zdrowia Dziecka
See details and how to join2024-515952-19-00 · EU 2024-515952-19-00
Phase 2/3Taking people
Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 Poland or AIEOP-BFM 2017 standard of care chemotherapy in children with acute lymphoblastic leukemia and confirmed activation of JAK/STAT pathway.
Where
Bialystok, Bydgoszcz, Cracow, Gdansk, Katowice, Kielce, Lodz, Lublin, Olsztyn, Poznan, Rzeszów, Szczecin, Warsaw, Wroclaw, Zabrze
Age
Up to 17 years
People
25
Run by
Medical University Of Lodz
See details and how to join2024-518316-39-00 · EU 2024-518316-39-00
No phaseTaking people
E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe
Where
Lodz, Radom, Warsaw
Age
12 years and over
People
2,000 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT03818503
Phase 2Taking people
To evaluate the efficacy and safety of naxitamab in patients with refractory Ewing's sarcoma.
Where
Warsaw, Wroclaw
Age
Up to 64 years
People
24
Run by
Instytut Matki I Dziecka
See details and how to join2024-514441-11-00 · EU 2024-514441-11-00
No phaseTaking people
International Chronic Myeloid Leukemia Pediatric Study
Where
Wroclaw
Age
Up to 18 years
People
750 worldwide
Run by
Poitiers University Hospital
See details and how to joinNCT01281735